42.1767335, -71.1908167

500 River Ridge Drive,
Second Floor,
Norwood, MA, 02062, United States

Corbus Pharmaceuticals Holdings Inc.

About Us

Corbus Pharmaceuticals Holdings Inc is a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. The company's lead product candidate, lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes. Lenabasum is currently being evaluated in systemic sclerosis, cystic fibrosis, dermatomyositis, and systemic lupus erythematosus.

CRBP
Corbus Pharmaceuticals Holdings Inc.
7.300
USD
0.03
(0.41%)